Rheumatoid Arthritis Clinical Trial
Official title:
Randomized Controlled Trial of a Physical Activity Intervention for RA Fatigue
The major goal of this project is to conduct a randomized, controlled trial of the impact of
a practical, low cost physical activity intervention on fatigue among persons with
rheumatoid arthritis (RA). Fatigue has been identified as a major concern for individuals
with RA, and is considered a core outcome measure for RA. Our recent study of the sources of
fatigue identified physical inactivity as a primary predictor of fatigue. Studies have
examined the impact of exercise interventions on RA outcomes, but most of these
interventions have focused on pain or function as outcomes. The few exercise studies
examining fatigue suggest that increasing physical activity reduces fatigue, but the
interventions have been resource-intensive, requiring specially trained personnel to
administer them, highly structured activities, and/or attendance at classes or a specified
facility. Each of these components increases the cost and barriers to implementation of an
intervention. Pedometers have been shown to be an effective means of increasing physical
activity, and could form the basis of a simple means to increase physical activity.
This project will test the effect of a simple pedometer-based intervention, with two
incremental degrees of guidance, on increasing physical activity and decreasing fatigue.
Three groups (n=40 in each) will be studied: a control group with an educational pamphlet
only, a pedometer-only intervention group, and a pedometer group with step targets. Both
intervention groups will keep step-count diaries. Groups will be followed over 20 weeks. We
expect that (1) the pedometer-only intervention group will increase activity more than the
education group, and the group with step-count targets will demonstrate even greater
increases in activity; and (2) greater increases in activity will be associated with greater
decreases in fatigue. Secondary outcome measures will include depressive symptoms,
self-reported sleep quality, and body composition. Our overall goal is to demonstrate an
effective, yet simple and low cost, physical activity intervention to decrease fatigue that
could be broadly accessible and have the potential for wide implementation.
Status | Active, not recruiting |
Enrollment | 120 |
Est. completion date | March 2016 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Physicians' diagnosis of RA - English verbal fluency - Residence in the greater San Francisco Bay Area - Score =20 on 10-item PROMIS fatigue scale, or at least one item rated "often" - BMI = 20 kg/m2 Exclusion Criteria: - Currently engaging in regular exercise - Non-ambulatory or presence of a condition or comorbid disease that would limit the ability to engage in walking (e.g., foot deformities, lower extremity joint surgery upcoming or in past 6 months, myocardial infarction in past 6 months, stroke, congestive heart failure, severe chronic obstructive pulmonary disease). |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of California, San Francisco | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PROMIS Fatigue scale | change from baseline fatigue score at 20 weeks | No | |
Secondary | Patient Health Questionnaire-9 (PHQ-9) | depressive symptoms | change from baseline PHQ-9 score at 20 weeks | No |
Secondary | Pittsburg Sleep Quality Index (PSQI) | self-reported sleep quality | Change from baseline PSQI score at 20 weeks | No |
Secondary | Change in weight | Change from baseline weight at 20 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |